Literature DB >> 2923488

Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.

P Colditz1, D Murphy, P Rolfe, A R Wilkinson.   

Abstract

Cerebrovascular responses were studied in preterm infants by Doppler ultrasound and cerebral electrical impedance for one hour after intravenous indomethacin infusion for patent ductus arteriosus. Indomethacin in a dose of 0.2 mg/kg body weight was infused over five minutes in one group of infants (20 doses) and over 20 minutes in a second group of infants (16 doses). There were no significant differences between the two groups in birth weight (mean = 1068 g, range 569-1950), gestational age (mean 28.4 weeks, range 25-31), or postnatal age (mean 18.1 days, range 6-42). There was a significant reduction in both the Doppler mean flow velocity in the anterior cerebral artery (mean (SE) -20 (4.2)%) and peak amplitude of cerebral electrical impedance (-26 (3.9)%) within two minutes of starting the indomethacin infusion over five minutes. There was no significant change after the infusion over 20 minutes. There were no significant changes in blood pressure or carbon dioxide tensions after infusion at either rate. The results suggest that infusion of indomethacin over five minutes caused a potentially deleterious reduction in cerebral blood flow. No such reduction occurred when it was infused over 20 minutes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923488      PMCID: PMC1590075          DOI: 10.1136/adc.64.1_spec_no.8

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  29 in total

1.  Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion.

Authors:  R J Anderson; T Berl; K M McDonald; R W Schrier
Journal:  Kidney Int       Date:  1976-09       Impact factor: 10.612

2.  Synthesis of prostaglandins and thromboxane B2 by cerebral arteries.

Authors:  A A Hagen; R P White; J T Robertson
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

3.  Arachidonate metabolism on the cerebral surface of newborn pigs.

Authors:  C W Leffler; D W Busija
Journal:  Prostaglandins       Date:  1985-11

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin.

Authors:  G J Peckham; O S Miettinen; R C Ellison; E N Kraybill; W M Gersony; S Zierler; A S Nadas
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

6.  Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.

Authors:  H W Seyberth; G Knapp; D Wolf; H E Ulmer
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

7.  The effect of indomethacin on breathing movements and cerebral blood flow and metabolism in the fetal sheep.

Authors:  A R Hohimer; B S Richardson; J M Bissonnette; C M Machida
Journal:  J Dev Physiol       Date:  1985-08

8.  Cerebral blood flow in the newborn infant: comparison of Doppler ultrasound and 133xenon clearance.

Authors:  G Greisen; K Johansen; P H Ellison; P S Fredriksen; J Mali; B Friis-Hansen
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

9.  Early administration of indomethacin to preterm infants.

Authors:  J M Rennie; J Doyle; R W Cooke
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

10.  Indomethacin therapy on the first day of life in infants with very low birth weight.

Authors:  L Mahony; R L Caldwell; D A Girod; R A Hurwitz; R D Jansen; J A Lemons; R L Schreiner
Journal:  J Pediatr       Date:  1985-05       Impact factor: 4.406

View more
  7 in total

Review 1.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Major pitfalls in Doppler investigations. Part II. Low flow velocities and colour Doppler applications.

Authors:  P Winkler; K Helmke; M Mahl
Journal:  Pediatr Radiol       Date:  1990

3.  Drug induced closure of patent ductus arteriosus.

Authors:  N Archer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 4.  Patent ductus arteriosus in the newborn.

Authors:  N Archer
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

5.  Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.

Authors:  N C Austin; P W Pairaudeau; T K Hames; M A Hall
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 6.  Comparative tolerability of pharmacological treatments for patent ductus arteriosus.

Authors:  C Hammerman; M Kaplan
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 7.  Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants.

Authors:  A S Görk; R A Ehrenkranz; M B Bracken
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.